ADA and Immunodeficiency: Santisteban et al. examined the genetic basis of adenosine deaminase (ADA) deficiency in seven patients with early or late immune deficiency and identified the substitution of serine at position 291 by amino acid leucine (S291L) in an ADA-deficient SCID patient, who showed improvement during red blood cell transfusion therapy [42].